https://www.selleckchem.com/pr....oducts/salinosporami
11[1.02-1.21] per 1-SD increase in Aβ4, driven by coronary heart disease (HR 1.17[1.05-1.29]) rather than stroke (HR 1.04[0.93-1.16]). However, excess risk of clinical outcomes was largely explained by baseline differences in cardiovascular risk factors and attenuated after further adjustment (for ASCVD- HR 1.05[0.96-1.15] and for CHD- HR 1.08[0.96-1.20]). Results were similar in the replication cohort, with highest risk estimates for CHD (HR 1.24[1.04-1.48]) in age- and sex-adjusted models, attenuated aft
Like
Comment
Share
